USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Safeguard Biosystems Holdings Ltd.

USPTO PatentsView assignee record - 11 granted patents across 11 technology areas, active 2017–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

23.4

Avg claims per patent

+20%

5-year filing velocity

The verdict

Safeguard holds 11 US patents across 11 technology areas, rank #25,102 of 50,000 tracked assignees.

#25,102
of 50,000 US assignees by volume: Top 23%
by Innovation Score (45.5/100): 23.4
avg claims per patent: +20%
filing velocity, last 5 yrs

Portfolio overview

Safeguard Biosystems Holdings Ltd. has been granted 11 US utility patents between 2017 and 2024, placing Safeguard Biosystems Holdings Ltd. at rank #25,102 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.4 claims per patent with primary concentration in B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE). As a Foreign Corporation, Safeguard Biosystems Holdings Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Safeguard sits between Royal Consumer Products Llc (11 patents, rank #25,098) and Samson ROPE Technologies, Inc. (11 patents, rank #25,106) - the closest US assignees by grant volume. The composite Innovation Score of 45.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 5 in the 2015–2019 window, a +20% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Safeguard Biosystems Holdings Ltd.'s 23.4 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Safeguard Biosystems Holdings Ltd. against peers pursuing similar technology classes.

Royal Consumer Pr…

11
Rxfunction

11
S-oil

11
Sabaf S P A

11
Safran Vectronix

11
Saint-gobain Abra…

11
Salvus

11
Samson ROPE

11
Safeguard Biosyst… ◀

11

What this shows Safeguard holds 11 patents at rank #25,102, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Safeguard's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

45 Top 23% higher than 77% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Safeguard Biosystems Holdings Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	9.1%
2018	2	18.2%
2019	2	18.2%
2021	1	9.1%
2022	1	9.1%
2023	1	9.1%
2024	3	27.3%

Which technologies does Safeguard Biosystems Holdings Ltd. patent most?

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 8

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 8

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 7

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 4

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 4

C08F - MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 2

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 2

C08J - WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H 2

C08L - COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 2

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 2

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 2

Top 11 of 11 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Complex

Velocity Growing

Where it ranks

Overall rank by patents

#25,102

Across all tracked assignees

Innovation Score

45.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Safeguard Biosystems Holdings Ltd. hold?

Safeguard Biosystems Holdings Ltd. holds 11 US granted patents filed between 2017 and 2024, spanning 11 technology areas.

What is Safeguard Biosystems Holdings Ltd.'s Innovation Score?

Safeguard Biosystems Holdings Ltd. has an Innovation Score of 45.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Safeguard Biosystems Holdings Ltd. focus on?

Safeguard Biosystems Holdings Ltd.'s top technology area is B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE) with 8 patents. The company has filed patents in 11 CPC subclasses total.

Is Safeguard Biosystems Holdings Ltd.'s patent filing rate increasing or decreasing?

Safeguard Biosystems Holdings Ltd.'s recent filing velocity is +20% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Safeguard Biosystems Holdings Ltd.'s patents?

Safeguard Biosystems Holdings Ltd.'s patents average 23.4 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Safeguard Biosystems Holdings Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Safeguard's 11 grants land it in the top 23% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Safeguard ranks #25,102 of 50,000. Top 50 holders
Most of this portfolio concentrates in B01L - see who else leads that technology area. B01L leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.